Beyond Air, Inc. Debt Conversion, Converted Instrument, Amount
Beyond Air, Inc. (XAIR) reported Debt Conversion, Converted Instrument, Amount of $18.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-06-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2019-06-28
- Beyond Air, Inc. debt conversion, converted instrument, amount for fiscal 2017 was $18.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2017-12-31 | $18.00K 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |